41 days


Joint Symposia

Friday, August 31 (16:20-17:50)
- Grand Ballroom A (3F)
Chairperson : TBD (Korea) 
Hidenori Arai (National Center for Geriatrics and Gerontology, Japan)

KSoLA - JAS (Japan Atherosclerosis Society) : How to Develop New Guidelines for ASCVD in Asia
16:20-16:40 Risk stratification of Japanese Patients with Dyslipidemia: Perspective for the Future ASCVD Guidelines Yoshihiro Miyamoto
National Cerebral and Cardiovascular Center, Japan
16:40-17:00 Current Status of Risk Factors and Prediction Models for Risk Stratification on ASCVD in Korea Sung Hoon Yu
Hanyang University, Korea
17:00-17:20 Lipid Management of Secondary Prevention in Japanese Population: Differences and Similarities Between East and West. Hiroyuki Daida
Juntendo University, Japan
17:20-17:40 New Treatment Guideline of Dyslipidemia in Korea In-Kyung Jeong
Kyung Hee University, Korea
17:40-17:50 Panel Discussion

Friday, August 31 (13:10-14:40)
- Grand Ballroom B (3F)
Chairperson : TBD

KSoLA - IAS (International Atherosclerosis Society) : Atherogenic TG and HDL Metabolism and Atherosclerosis
13:10-13:30 PPAR gamma Phosphorylation and Metabolic Disease Jang Hyun Choi
UNIST, Korea
13:30-13:50 Roles of HDL and Cholesteryl Ester Transfer Protein in the Prevention of Atherosclerosis: Lesson from the Development of CETP Inhibitors and Subjects with CETP Deficiency Matsuzawa Yuji
Osaka University, Japan
13:50-14:10 Dietary Fat, Atherogenic Dyslipidemia and Cardiometabolic Health Min-Jeong Shin
Korea University, Korea
14:10-14:30 Impact of Pemafibrate for the Management of Dyslipidemia Hidenori Arai
National Center for Geriatrics and Gerontology, Japan
14:30-14:40 Panel Discussion

Saturday, September 1 (15:50-17:20)
- Grand Ballroom A (3F)
Chairperson : Ian M Graham (Trinity College, Ireland)
Kyung-Woo Park (Seoul National University, Korea)

KSoLA – ESC (European Society of Cardiology) ; Atherosclerosis : New Target on LDL and Inflammation
15:50-16:10 Basic Science Perspective; New Aspects of the Patho-biology of Atherosclerosis : The Role of Lipids & Inflammation Alberico Catapano
University of Milano, Italy
16:10-16:30 Identification of New Molecule to Mediate Binding of PCSK9 and LDL-Receptor -- New Insight on Action Mechanism of PCSK9 to Degrade LDL-R -- Hyo-Soo Kim
Seoul National University, Korea
16:30-16:50 Clinical Perspective: Current LDL-cholesterol Goals- Are They Appropriate? Ian M Graham
Trinity College, Ireland
16:50-17:10 The Future: Future Directions for Research into LDL Lowering, Anti-inflammatory Drugs and Interactions Sang-Hyun Kim
Seoul National University, Korea
17:10-17:20 Panel Discussion

Saturday, September 1 (13:50-15:20)
- Grand Ballroom A (3F)
Chairperson : TBD

KSoLA-KSSO-KSCMS - Obesity and Atherosclerosis
13:50-14:05 Obesity and Pathogenesis of Atherosclerosis Soo Lim
Seoul National University, Korea
14:05-14:20 Metabolically Healthy Obesity & Metabolically Unhealthy Obesity Eun Jung Rhee
Sungkyunkwan University, Korea
14:20-14:35 Fat Distribution or Amount ; What is More Important? Dae Jung Kim
Ajou University, Korea
14:35-14:50 Non-Pharmacological Treatment of Obesity Mi-Kyung Kim
Keimyung University, Korea
14:50-15:05 Pharmacological Treatment of Obesity Yong-ho Lee
Yonsei University, Korea
15:05-15:20 Panel Discussion